Noninvasive test may be a good measure of proliferative activity in suspicious breast lesions.(Brief Article)
Publication: Medical Devices & Surgical Technology Week
Publication Date: 19-MAY-02
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2002 MAY 19 - (NewsRx.com & NewsRx.net) -- Biofield Corp. (BZET) announced that, during the 3rd European Breast Cancer Conference in Barcelona, Spain, a scientific poster was presented which reflected initial results of concordance between the biofield diagnostic system test and Ki-67 labeling index.
Analysis of preliminary results of...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
